Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria · Delayed Price · Currency is BGN 17.10
+0.20 (1.18%)
At close: Aug 19, 2025
BUL:THQM Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 58.44 | 53.14 | 48.51 | 43.15 | 42.43 | 40.11 | Upgrade |
| 58.44 | 53.14 | 48.51 | 43.15 | 42.43 | 40.11 | Upgrade | |
Revenue Growth (YoY) | 18.08% | 9.54% | 12.44% | 1.69% | 5.80% | 15.50% | Upgrade |
Cost of Revenue | 12.86 | 20.32 | 33.54 | 12.81 | 30.77 | 30.01 | Upgrade |
Gross Profit | 45.58 | 32.82 | 14.98 | 30.34 | 11.67 | 10.1 | Upgrade |
Selling, General & Admin | 35.28 | 24.73 | 7.33 | 23.99 | 5.68 | 4.96 | Upgrade |
Other Operating Expenses | 0.46 | 0.3 | 0.83 | -0.27 | 0.65 | 0.32 | Upgrade |
Operating Expenses | 38.38 | 27.55 | 10.97 | 27.29 | 10.21 | 9.51 | Upgrade |
Operating Income | 7.2 | 5.27 | 4.01 | 3.05 | 1.46 | 0.59 | Upgrade |
Interest Expense | -0.52 | -0.59 | -0.55 | -0.28 | -0.27 | -0.24 | Upgrade |
Interest & Investment Income | 0.48 | 0.48 | 0.46 | 0.47 | 0.46 | 0.45 | Upgrade |
Currency Exchange Gain (Loss) | -0.03 | -0.09 | -0.01 | -0.07 | -0.06 | -0.03 | Upgrade |
Other Non Operating Income (Expenses) | -0.04 | -0.04 | -0.04 | -0.04 | -0.02 | -0.15 | Upgrade |
EBT Excluding Unusual Items | 7.09 | 5.03 | 3.87 | 3.13 | 1.56 | 0.62 | Upgrade |
Pretax Income | 7.09 | 5.03 | 3.87 | 3.13 | 1.56 | 0.62 | Upgrade |
Income Tax Expense | 0.62 | 0.54 | 0.47 | 0.34 | 0.17 | 0.2 | Upgrade |
Net Income | 6.47 | 4.49 | 3.4 | 2.79 | 1.4 | 0.43 | Upgrade |
Net Income to Common | 6.47 | 4.49 | 3.4 | 2.79 | 1.4 | 0.43 | Upgrade |
Net Income Growth | 236.10% | 32.12% | 21.86% | 99.86% | 226.17% | -83.33% | Upgrade |
Shares Outstanding (Basic) | 97 | 96 | 93 | 93 | 93 | 67 | Upgrade |
Shares Outstanding (Diluted) | 97 | 96 | 93 | 93 | 93 | 67 | Upgrade |
Shares Change (YoY) | 5.07% | 3.38% | - | - | 38.72% | -24.86% | Upgrade |
EPS (Basic) | 0.07 | 0.05 | 0.04 | 0.03 | 0.02 | 0.01 | Upgrade |
EPS (Diluted) | 0.07 | 0.05 | 0.04 | 0.03 | 0.02 | 0.01 | Upgrade |
EPS Growth | 219.89% | 27.80% | 21.87% | 99.86% | 135.13% | -77.82% | Upgrade |
Free Cash Flow | 1.11 | 1.2 | 0.96 | 0.88 | 0.45 | 0.58 | Upgrade |
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade |
Gross Margin | 77.99% | 61.76% | 30.87% | 70.31% | 27.49% | 25.18% | Upgrade |
Operating Margin | 12.32% | 9.92% | 8.26% | 7.06% | 3.43% | 1.47% | Upgrade |
Profit Margin | 11.07% | 8.45% | 7.01% | 6.47% | 3.29% | 1.07% | Upgrade |
Free Cash Flow Margin | 1.90% | 2.25% | 1.97% | 2.04% | 1.06% | 1.44% | Upgrade |
EBITDA | 9.06 | 7.77 | 6.81 | 6.38 | 5.3 | 4.82 | Upgrade |
EBITDA Margin | 15.51% | 14.62% | 14.04% | 14.78% | 12.50% | 12.02% | Upgrade |
D&A For EBITDA | 1.87 | 2.5 | 2.8 | 3.33 | 3.85 | 4.23 | Upgrade |
EBIT | 7.2 | 5.27 | 4.01 | 3.05 | 1.46 | 0.59 | Upgrade |
EBIT Margin | 12.32% | 9.92% | 8.26% | 7.06% | 3.43% | 1.47% | Upgrade |
Effective Tax Rate | 8.68% | 10.73% | 12.14% | 10.92% | 10.74% | 31.41% | Upgrade |
Revenue as Reported | 5.17 | - | - | - | 42.56 | 40.39 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.